Literature DB >> 29334544

Blood biomarkers of expressed and inducible HIV-1.

Anthony R Cillo1,2, Francis Hong1, Angela Tsai3, Alivelu Irrinki3, Jasmine Kaur3, Derek D Sloan3,4, Mattie Follen1, Romas Geleziunas3, Tomas Cihlar3, Sandra S Win5, Jeffrey P Murry3, John W Mellors1.   

Abstract

OBJECTIVE: To define the relationships between molecular measures of viral persistence in blood (i.e., plasma viremia, cellular HIV-1 DNA, and mRNA) and expressed or inducible virus from resting CD4 T cells of individuals on suppressive antiretroviral therapy.
DESIGN: We compared molecular measurements of HIV-1 in plasma and in uncultured peripheral blood mononuclear cells (PBMCs) to the levels of virions produced by either unstimulated or phorbol myristate acetate and ionomycin (PMA/iono)-stimulated PBMC or resting CD4 T cells from 21 donors on suppressive antiretroviral therapy.
RESULTS: We found that unstimulated virion release from cultured resting CD4 T cells was positively correlated with the levels of plasma viremia in vivo (Spearman rho = 0.67, P = 0.0017). We also found that levels of both cellular HIV-1 DNA and unspliced HIV-1 mRNA per million uncultured PBMC were positively correlated with the levels of inducible virion release from both PMA/iono-stimulated PBMC (total HIV-1 DNA: rho = 0.64, P = 0.0017; unspliced HIV-1 RNA: rho = 0.77, P < 0.001) and PMA/iono-stimulated resting CD4 T cells (total HIV-1 DNA: rho = 0.75, P < 0.001; unspliced HIV-1 RNA: rho = 0.75, P < 0.001).
CONCLUSION: These results show for the first time that there are strong associations between in-vivo measures of HIV-1 persistence and ex-vivo measures of spontaneous and inducible virus production from cultured PBMC and resting CD4 T cells. Findings from this study provide insight into the biology of HIV-1 persistence and suggest methods to guide the evaluation of clinical strategies to reduce the size of the viral reservoir.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29334544      PMCID: PMC5854535          DOI: 10.1097/QAD.0000000000001748

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  51 in total

1.  Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

Authors:  Janet D Siliciano; Joleen Kajdas; Diana Finzi; Thomas C Quinn; Karen Chadwick; Joseph B Margolick; Colin Kovacs; Stephen J Gange; Robert F Siliciano
Journal:  Nat Med       Date:  2003-05-18       Impact factor: 53.440

2.  HIV-1 Virion Production from Single Inducible Proviruses following T-Cell Activation Ex Vivo.

Authors:  John K Bui; John W Mellors; Anthony R Cillo
Journal:  J Virol       Date:  2015-11-11       Impact factor: 5.103

3.  Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption.

Authors:  Meghan K Rothenberger; Brandon F Keele; Stephen W Wietgrefe; Courtney V Fletcher; Gregory J Beilman; Jeffrey G Chipman; Alexander Khoruts; Jacob D Estes; Jodi Anderson; Samuel P Callisto; Thomas E Schmidt; Ann Thorkelson; Cavan Reilly; Katherine Perkey; Thomas G Reimann; Netanya S Utay; Krystelle Nganou Makamdop; Mario Stevenson; Daniel C Douek; Ashley T Haase; Timothy W Schacker
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-23       Impact factor: 11.205

4.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

Authors:  T W Chun; L Stuyver; S B Mizell; L A Ehler; J A Mican; M Baseler; A L Lloyd; M A Nowak; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

5.  Integrated HIV DNA accumulates prior to treatment while episomal HIV DNA records ongoing transmission afterwards.

Authors:  John M Murray; Kristin McBride; Christoph Boesecke; Michelle Bailey; Janaki Amin; Kazuo Suzuki; David Baker; John J Zaunders; Sean Emery; David A Cooper; Kersten K Koelsch; Anthony D Kelleher
Journal:  AIDS       Date:  2012-03-13       Impact factor: 4.177

6.  HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation.

Authors:  Nicolas Chomont; Mohamed El-Far; Petronela Ancuta; Lydie Trautmann; Francesco A Procopio; Bader Yassine-Diab; Geneviève Boucher; Mohamed-Rachid Boulassel; Georges Ghattas; Jason M Brenchley; Timothy W Schacker; Brenna J Hill; Daniel C Douek; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sékaly
Journal:  Nat Med       Date:  2009-06-21       Impact factor: 53.440

7.  HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy.

Authors:  Guillaume J Besson; Christina M Lalama; Ronald J Bosch; Rajesh T Gandhi; Margaret A Bedison; Evgenia Aga; Sharon A Riddler; Deborah K McMahon; Feiyu Hong; John W Mellors
Journal:  Clin Infect Dis       Date:  2014-07-29       Impact factor: 9.079

8.  Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay.

Authors:  Gregory M Laird; Evelyn E Eisele; S Alireza Rabi; Jun Lai; Stanley Chioma; Joel N Blankson; Janet D Siliciano; Robert F Siliciano
Journal:  PLoS Pathog       Date:  2013-05-30       Impact factor: 6.823

9.  HIV-1 DNA predicts disease progression and post-treatment virological control.

Authors:  James P Williams; Jacob Hurst; Wolfgang Stöhr; Nicola Robinson; Helen Brown; Martin Fisher; Sabine Kinloch; David Cooper; Mauro Schechter; Giuseppe Tambussi; Sarah Fidler; Mary Carrington; Abdel Babiker; Jonathan Weber; Kersten K Koelsch; Anthony D Kelleher; Rodney E Phillips; John Frater
Journal:  Elife       Date:  2014-09-12       Impact factor: 8.140

10.  Integrated and Total HIV-1 DNA Predict Ex Vivo Viral Outgrowth.

Authors:  Maja Kiselinova; Ward De Spiegelaere; Maria Jose Buzon; Eva Malatinkova; Mathias Lichterfeld; Linos Vandekerckhove
Journal:  PLoS Pathog       Date:  2016-03-03       Impact factor: 6.823

View more
  10 in total

1.  Different human resting memory CD4+ T cell subsets show similar low inducibility of latent HIV-1 proviruses.

Authors:  Kyungyoon J Kwon; Andrew E Timmons; Srona Sengupta; Francesco R Simonetti; Hao Zhang; Rebecca Hoh; Steven G Deeks; Janet D Siliciano; Robert F Siliciano
Journal:  Sci Transl Med       Date:  2020-01-29       Impact factor: 17.956

2.  A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infection.

Authors:  Eugène D M B Kroon; Jintanat Ananworanich; Amélie Pagliuzza; Ajantha Rhodes; Nittaya Phanuphak; Lydie Trautmann; Julie L Mitchell; Michelle Chintanaphol; Jintana Intasan; Suteeraporn Pinyakorn; Khuntalee Benjapornpong; J Judy Chang; Donn J Colby; Nitiya Chomchey; James L K Fletcher; Keith Eubanks; Hua Yang; John Kapson; Ashanti Dantanarayana; Surekha Tennakoon; Robert J Gorelick; Frank Maldarelli; Merlin L Robb; Jerome H Kim; Serena Spudich; Nicolas Chomont; Praphan Phanuphak; Sharon R Lewin; Mark S de Souza
Journal:  J Virus Erad       Date:  2020-07-18

3.  Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART.

Authors:  Nadine Bachmann; Chantal von Siebenthal; Valentina Vongrad; Teja Turk; Kathrin Neumann; Niko Beerenwinkel; Jasmina Bogojeska; Jaques Fellay; Volker Roth; Yik Lim Kok; Christian W Thorball; Alessandro Borghesi; Sonali Parbhoo; Mario Wieser; Jürg Böni; Matthieu Perreau; Thomas Klimkait; Sabine Yerly; Manuel Battegay; Andri Rauch; Matthias Hoffmann; Enos Bernasconi; Matthias Cavassini; Roger D Kouyos; Huldrych F Günthard; Karin J Metzner
Journal:  Nat Commun       Date:  2019-07-19       Impact factor: 14.919

4.  Mucosal integrin α4β7 blockade fails to reduce the seeding and size of viral reservoirs in SIV-infected rhesus macaques.

Authors:  Widade Ziani; Jiasheng Shao; Angela Fang; Patrick J Connolly; Xiaolei Wang; Ronald S Veazey; Huanbin Xu
Journal:  FASEB J       Date:  2021-02       Impact factor: 5.834

5.  Predicting Post-treatment HIV Remission: Does Size of the Viral Reservoir Matter?

Authors:  Alexander O Pasternak; Christina K Psomas; Ben Berkhout
Journal:  Front Microbiol       Date:  2021-02-26       Impact factor: 5.640

6.  Immune Responses and Viral Persistence in Simian/Human Immunodeficiency Virus SHIV.C.CH848-Infected Rhesus Macaques.

Authors:  Widade Ziani; Anya Bauer; Hong Lu; Xiaolei Wang; Xueling Wu; Katharine J Bar; Hui Li; Dongfang Liu; George M Shaw; Ronald S Veazey; Huanbin Xu
Journal:  J Virol       Date:  2021-04-12       Impact factor: 6.549

7.  Randomized Clinical Trial to Assess the Impact of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 on HIV-1 Persistence in Individuals on Effective ART.

Authors:  Sharon A Riddler; Lu Zheng; Christine M Durand; Justin Ritz; Richard A Koup; Julie Ledgerwood; Robert T Bailer; Susan L Koletar; Joseph J Eron; Michael C Keefer; Bernard J C Macatangay; Joshua C Cyktor; John W Mellors
Journal:  Open Forum Infect Dis       Date:  2018-10-20       Impact factor: 3.835

8.  Blockade of the PD-1 axis alone is not sufficient to activate HIV-1 virion production from CD4+ T cells of individuals on suppressive ART.

Authors:  John K Bui; Joshua C Cyktor; Elizabeth Fyne; Shalyn Campellone; Stephen W Mason; John W Mellors
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

9.  Replicate Aptima Assay for Quantifying Residual Plasma Viremia in Individuals on Antiretroviral Therapy.

Authors:  Sonia Bakkour; Xutao Deng; Peter Bacchetti; Eduard Grebe; Leilani Montalvo; Andrew Worlock; Mars Stone; Steven G Deeks; Douglas D Richman; Michael P Busch
Journal:  J Clin Microbiol       Date:  2020-11-18       Impact factor: 5.948

Review 10.  Residual Proviral Reservoirs: A High Risk for HIV Persistence and Driving Forces for Viral Rebound after Analytical Treatment Interruption.

Authors:  Xiaolei Wang; Huanbin Xu
Journal:  Viruses       Date:  2021-02-21       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.